AbCellera Biologics Inc.

ABCL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001703057

SEC filings (opens in a new tab)

In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding AbCellera Biologics Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of ABCL: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	116	124	+8
Shares	98.7M	114.5M	+15.8M (+16.0%)
Value	$1.98B	$1.63B	−$348.9M (−17.6%)

New holders (33)

Institutions that held AbCellera Biologics Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ABCL in Q4 2021
Institution	Shares	Value	% of portfolio
DCVC Bio GP, LLC	7,305,761	$104.5M	100.00%
Canada Pension Plan Investment Board	435,400	$6.23M	0.01%
Founders Fund Growth Management, LLC	407,017	$5.82M	3.28%
TD Waterhouse Canada Inc.	180,955	$2.84M	0.03%
DekaBank Deutsche Girozentrale	195,000	$2.65M	0.01%
Susquehanna Fundamental Investments, LLC	146,937	$2.10M	0.06%
BlueCrest Capital Management Ltd	143,307	$2.05M	0.12%
Alliancebernstein L.P.	125,000	$1.79M	0.00%
Paloma Partners Management Co	87,167	$1.25M	0.04%
Group One Trading, L.P.	84,531	$1.21M	0.02%
ExodusPoint Capital Management, LP	82,825	$1.18M	0.01%
JPMorgan Chase & Co	82,038	$1.17M	0.00%
Trexquant Investment LP	57,107	$817.0K	0.05%
Nomura Asset Management Co Ltd	54,830	$784.1K	0.00%
ProShare Advisors LLC	39,653	$567.0K	0.00%
Occudo Quantitative Strategies LP	26,867	$384.0K	0.03%
JFS Wealth Advisors, LLC	26,064	$373.0K	0.04%
Rothschild Investment Corp	26,000	$372.0K	0.03%
Graham Capital Management, L.P.	25,727	$367.0K	0.02%
Quent Capital, LLC	21,050	$301.0K	0.06%
Qube Research & Technologies Ltd	19,673	$281.0K	0.00%
Searle & Co.	13,900	$199.0K	0.07%
Nan Fung Group Holdings Ltd	13,180	$188.0K	0.06%
Quantamental Technologies LLC	12,080	$173.0K	0.09%
Cedar Brook Financial Partners, LLC	11,715	$168.0K	0.04%
Dark Forest Capital Management LP	3,184	$46.0K	0.02%
Spire Wealth Management	2,000	$29.0K	0.00%
National Bank of Canada	1,145	$16.0K	0.00%
Daiwa Securities Group Inc.	822	$12.0K	0.00%
Migdal Insurance & Financial Holdings Ltd.	595	$9.00K	0.00%
Beaird Harris Wealth Management, LLC	300	$4.00K	0.00%
Reilly Financial Advisors, LLC	100	$1.00K	0.00%
Bivin & Associates, Inc.	50	$1.00K	0.00%

Sold out (25)

Institutions that held AbCellera Biologics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ABCL in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Clough Capital Partners L P	971,297	$19.5M
Marshall Wace, LLP	338,120	$6.78M
Ergoteles LLC	331,414	$6.64M
Point72 Asset Management, L.P.	272,984	$5.47M
Temasek Holdings (Private) Ltd	246,907	$4.95M
Pendal Group Limited	64,826	$1.30M
Cinctive Capital Management LP	60,000	$1.20M
Schonfeld Strategic Advisors LLC	57,540	$1.15M
Seven Eight Capital, LP	54,345	$1.09M
Man Group plc	49,165	$985.0K
Bank of New York Mellon Corp	28,613	$573.0K
Invesco Ltd.	28,110	$563.0K
Polar Asset Management Partners Inc.	25,000	$501.0K
Myriad Asset Management Ltd.	25,000	$501.0K
Tudor Investment Corp Et Al	15,121	$303.0K
PEAK6 Investments LLC	12,282	$246.0K
United Capital Financial Advisers, LLC	10,650	$213.0K
Deutsche Bank AG	6,888	$138.0K
Focused Wealth Management, Inc	1,000	$20.0K
Arkadios Wealth Advisors	700	$14.0K
Gerber Kawasaki Wealth & Investment Management	500	$10.0K
Evolution Wealth Advisors, LLC	415	$8.00K
Patriot Financial Group Insurance Agency, LLC	100	$2.00K
Harbour Investments, Inc.	27	$1.00K
Point72 Hong Kong Ltd	52	$1.00K